Kyntra Bio (KYNB) Receivables (2016 - 2025)
Historic Receivables for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $121000.0.
- Kyntra Bio's Receivables fell 9978.97% to $121000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $121000.0, marking a year-over-year decrease of 9978.97%. This contributed to the annual value of $29.0 million for FY2024, which is 1380.09% down from last year.
- According to the latest figures from Q3 2025, Kyntra Bio's Receivables is $121000.0, which was down 9978.97% from $136000.0 recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Receivables registered a high of $82.6 million during Q1 2022, and its lowest value of $121000.0 during Q3 2025.
- Its 5-year average for Receivables is $38.5 million, with a median of $34.9 million in 2024.
- As far as peak fluctuations go, Kyntra Bio's Receivables skyrocketed by 12446.86% in 2024, and later plummeted by 9978.97% in 2025.
- Over the past 5 years, Kyntra Bio's Receivables (Quarter) stood at $28.3 million in 2021, then grew by 0.2% to $28.4 million in 2022, then grew by 18.44% to $33.6 million in 2023, then fell by 13.8% to $29.0 million in 2024, then tumbled by 99.58% to $121000.0 in 2025.
- Its Receivables stands at $121000.0 for Q3 2025, versus $136000.0 for Q2 2025 and $147000.0 for Q1 2025.